Descriptions:
Term | description type | Language/acceptability | Language/acceptability | Case significance |
---|---|---|---|---|
Product containing precisely [substance][number][Numerator Unit of measure ]/[1][Denominator Unit of measure ] [dose form] (clinical drug) | FSN | us:P | gb:P | ci |
[substance] [number] [Unit of measure ] [dose form] | SYN | us:P | gb:P | ci |
Concept model:
Attribute cardinality | Attribute | Value | role group number | role group cardinality |
---|---|---|---|---|
0 | N/A | |||
1..1 | 0 | |||
1..1 | 0 | |||
1..1 | 0 | |||
0..1 | 0 | |||
0..1 | 0 | |||
1..1 | 1..* | 1..* @group | ||
1..1 | 1..* | |||
1..1 | 1..* | |||
1..1 | 1..* | |||
1..1 | 1..* | |||
0..1 | 1..* |
Definition status:
900000000000073002 |Defined (core metadata concept)|
Rules for description generation:
- Apply General rules for generating descriptions for templates
For multiple ingredients, the BoSS substance ingredients in each description need to be in alphabetical order
For multiple ingredients, for FSN add 'and [substance][number][Unit of measure ]' after the first [substance][number][Unit of measure ] for each |Has basis of strength substance (attribute)| Example:
Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug)For multiple ingredients PT - add ' [substance][number][Unit of measure ] and' at the beginning of the PT Example; Lopinavir 80 mg/mL and ritonavir 20 mg/mL oral solution
- DRUGS-548Getting issue details... STATUS
- DRUGS-646Getting issue details... STATUS